Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Acadia Healthcare Company, Inc. (ACHC:NASDAQ), powered by AI.
Acadia Healthcare Company, Inc. is currently trading at $24.99. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Acadia Healthcare Company, Inc. on Alpha Lenz.
Acadia Healthcare Company, Inc.'s P/E ratio is -2.1.
“Acadia Healthcare Company, Inc. trades at a P/E of -2.1 (undervalued) with modest ROE of -43.9%.”
Ask for details →Acadia Healthcare Company, Inc. is a prominent provider in the healthcare sector, focusing primarily on offering behavioral healthcare services in various facilities across the United States and the United Kingdom. The primary function of Acadia Healthcare is to cater to those requiring mental health and addiction treatment, ensuring a comprehensive approach to care. With a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic school-based programs, Acadia covers a broad spectrum of mental health needs. The company's operational focus on quality care and a diverse range of services plays a crucial role in supporting community health and addressing the rising demand for mental health services. As the stigma around mental health continues to decrease, the significance of Acadia Healthcare's services becomes increasingly vital within the healthcare market, meeting the needs of underserved patient populations and collaborating with government health agencies to expand access to care.
“Acadia Healthcare Company, Inc. trades at a P/E of -2.1 (undervalued) with modest ROE of -43.9%.”
Ask for details →Acadia Healthcare Company, Inc. (ticker: ACHC) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 19,192 employees. Market cap is $2.3B.
The current price is $24.99 with a P/E ratio of -2.06x and P/B of 1.16x.
ROE is -43.91% and operating margin is 11.71%. Annual revenue is $3.3B.